FC
LEGN icon

Financial Consulate’s Legend Biotech LEGN Stock Holding History

Financial Consulate’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74K Buy
+96
New +$1.83K ﹤0.01% 1005

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Financial Consulate's LEGN Position: Q1 2026 in Review

Financial Consulate opened a new position in Legend Biotech (LEGN) in Q1 2026: 96 shares worth $1.74K. The stake represents ﹤0.01% of the portfolio and ranks #1005 among its holdings.

189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Financial Consulate held 96 shares of Legend Biotech worth $1.74K as of Q1 2026.
  • Legend Biotech was a new Financial Consulate position in Q1 2026.
  • Legend Biotech made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #1005 holding.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.